Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :5446
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers
Robert S. Epstein,Roshanthi K. Weerasinghe,Amy S. Parrish,JoAnn Krenitsky,Rachel E. Sanborn,Tehseen Salimi
Journal of Medical Economics.2022;25(1)108
2Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients
Laura A. Hatfield,Haiden A. Huskamp,Elizabeth B. Lamont
Journal of Oncology Practice.2016;12(7)666
3Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study
Annemiek M. van Maldegem,Charlotte Benson,Piotr Rutkowski,Jean-Yves Blay,Henk van den Berg,Joanna Placzke,Meybrit Rasper,Ian Judson,Heribert Juergens,Uta Dirksen,Hans Gelderblom
Pediatric Blood & Cancer.2015;62(1)40
4Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors
Ondrej Kubecek,Pavla Paterová,Martina Novosadová
5Carboplatin (Renally Dosed) and Etoposide Regimen for Small-Cell Lung Cancer
Matthew R. Rutledge,J. Aubrey Waddell,Dominic A. Solimando
Hospital Pharmacy.2013;48(4)274
6Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience
M.V. Bluthgen,C. Boutros,F. Fayard,J. Remon,D. Planchard,B. Besse
Lung Cancer.2016;99(4)111
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow